Heterodimerization is mainly responsible for the dominant negative activity of amino-terminally truncated rat androgen receptor forms

FEBS Letters

Volumn 430, Issue 3, 1998, Pages 393-396

  Ikonen, T ^a   Palvimo, J J ^a   Janne O A ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Androgen receptor; DNA binding; Dominant negative mutant; Heterodimer formation; Transactivation

Indexed keywords

ANDROGEN RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; GENE MUTATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DNA BINDING; RAT; TRANSACTIVATION;

ANIMALS; CELL LINE; COS CELLS; DIMERIZATION; DNA; HAPLORHINI; PROTEIN BINDING; RATS; RECEPTORS, ANDROGEN; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; TRANS-ACTIVATION (GENETICS); TYROSINE TRANSAMINASE;

EID: 0032479369     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00701-7     Document Type: Article

References (19)

1. Quigley C.A., DeBellis A., Marschke K.B., El-Awady M.K., Wilson E.M., French F.S. Endocr. Rev. 16:1995;271-321.
2. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. Cell. 83:1995;835-839.
3. Beato M., Herrlich P., Schütz G. Cell. 83:1995;851-857.
4. Refetoff S., Weiss R.E., Usala S.J. Endocr. Rev. 14:1993;348-399.
5. Sakurai A., Miyamoto T., Refetoff S., DeGroot L.J. Mol. Endocrinol. 4:1990;1988-1994.
6. Meier C.A., Dickstein B.M., Ashizawa K., McClaskey J.H., Muchmore P., Ransom S.C., Menke J.B., Hao E.-H., Usala S.J., Bercu B.B., Cheng S.-Y., Weintraub B.D. Mol. Endocrinol. 6:1992;248-258.
7. Sluyser M. Hum. Mut. 6:1995;97-103.
8. Palvimo J.J., Kallio P.J., Ikonen T., Mehto M., Jänne O.A. Mol. Endocrinol. 7:1993;1399-1407.
9. Reinikainen P., Palvimo J.J., Jänne O.A. Endocrinology. 137:1996;4351-4357.
10. Kallio P.J., Poukka H., Moilanen A., Jänne O.A., Palvimo J.J. Mol. Endocrinol. 9:1995;1017-1028.
11. Ikonen T., Palvimo J.J., Jänne O.A. J. Biol. Chem. 272:1997;29821-29828.
12. Kallio P.J., Palvimo J.J., Mehto M., Jänne O.A. J. Biol. Chem. 269:1994;11514-11522.
13. Ikonen T., Palvimo J.J., Kallio P.J., Reinikainen P., Jänne O.A. Endocrinology. 135:1994;1359-1366.
14. Eastman A. BioTechniques. 5:1987;73.
15. Rosenthal N. Methods Enzymol. 152:1987;704-720.
16. Karvonen U., Kallio P.J., Jänne O.A., Palvimo J.J. J. Biol. Chem. 272:1997;15973-15979.
17. Yen P.M., Chin W.W. Mol. Endocrinol. 8:1994;1450-1454.
18. Yen P.M., Liu Y., Palvimo J.J., Trifiro M., Whang J., Pinsky L., Jänne O.A., Chin W.W. Mol. Endocrinol. 11:1997;162-171.
19. Vegeto E., Shahbaz M.M., Wen D.X., Goldman M.E., O'Malley B.W., McDonnell D.P. Mol. Endocrinol. 7:1993;1244-1255.